Press Release Description

Global Tissue Imaging Market is expected to grow at a CAGR of 8.96% during 2021-26

According to the MarkNtel Advisors' research report, "Global Tissue Imaging Market Analysis, 2021," the market is likely to grow at a CAGR of 8.96% during 2021-26, owes to factors like the increasing identification of the early signs and detection of diseases and diagnosis, the rising chronic disease cases. Hence, the market is likely to grow in the forecast period. The extensive investments by businesses across the globe in the healthcare sector, advanced technologies like AI & machine learning also fuel the market growth. 

Key questions answered in the study

  1. What are the current and future trends in the Global Tissue Imaging Market?
  2. How has the industry been evolving in terms of geography and services adoption?
  3. How has the competition been shaping across the countries, followed by their comparative factorial indexing?
  4. What are the key growth drivers and challenges for the Global Tissue Imaging Market?
  5. What are the customer orientation, purchase behavior, and expectations from the Global Tissue Imaging Market service providers across various regions?

Pharmaceutical Companies To Hold Exponential Share

Based on end-user industries, Pharmaceutical Companies are likely to hold an exponential market share in the coming years due to the burgeoning demand for the supply of tissue imaging tools in developing drugs and other diagnosis processes & research. Additionally, several factors like well-resourced surgical rooms & operation centers, higher purchasing power, extensive availability of skilled professionals, and better health coverage insurances further drive the market growth.

“Global Tissue Imaging Market Analysis, 2021” provides comprehensive, qualitative, and quantitative insights on the market potential, key factors impacting the market growth, hotspots, and opportunities available for Tissue Imaging providers across the globe. Moreover, the report also encompasses the key strategic imperatives for competitors' success and strategic factorial indexing to measure their capabilities on 16 parameters, which will help companies to formulate 'Go to Market' strategies and identify the blue ocean for their offerings.

North America Holds The Largest Market Share. 

The North American market holds the largest share in the Global Tissue Imaging Market during 2021-26. The easy access to high-level technologies, government initiatives to diagnose cancer patients, increasing healthcare expenditure, promising reimbursement for pathology diagnostic tests, and high-quality infrastructure in North America are factors driving the tissue imaging market growth. Therefore, North America is likely to contribute to the Global Tissue Imaging Market growth in the forecast period, reveals MarkNtel Advisors research report, "Global Tissue Imaging Market Analysis, 2021."

According to MarkNtel Advisors, the major leading players in the Global Tissue Imaging Market are Abbott Laboratories, Abcam Plc, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Inc., Danaher Corporation, Olympus Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Hamamatsu Photonics K.K., Dickinson & Company, Becton, Nikon Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., and Shimadzu Corporation, among others.

Market Segmentation:

  1. By Product (Mass Spectroscopy Imaging (MSI) platforms, Flow Cytometry Analyzers, Digital Pathology Scanners, Immunohistochemistry Detection Systems, In-Situ Hybridization Platforms, Immunofluorescence Imaging Analysis Systems, Tissue Microarray Platforms, Optical Microscopes, Compound Microscopes, Digital Microscopes, Fluorescence Microscopes, Antibodies & Reagents, Kits, Probes.)
  2. By Application (Oncology Research, Infectious Diseases Research, Neurological Disease Research, Cardiovascular Disease Research, Immunological Disease Research
  3. Other Diseases Research)
  4. By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa)
  5. By Country (U.S, Canada, Brazil, Argentina, Mexico, Germany, France, The U.K, The Netherlands, Spain, Italy, China, India, Japan, Australia, Saudi Arabia, South Africa)
  6. By Competitors (Abbott Laboratories, Abcam Plc, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Inc., Danaher Corporation, Olympus Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Hamamatsu Photonics K.K., Dickinson & Company, Becton, Nikon Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., and Shimadzu Corporation, among others.)